Cited by 185Advanced biosensing and bioanalysis techniquesNanoplatforms for cancer theranosticsOvarian cancer diagnosis and treatment

Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant

Open access
Williams, Ryan M., Lee, Christopher, Galassi, Thomas V., Harvey, Jackson D., Leicher, Rachel, Sirenko, Maria, Dorso, Madeline A., Shah, Janki +4 more·2018·Science Advances

Abstract

Ovarian cancer biomarker detection using a novel nanosensor implant in live mice.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.aaq1090

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [15]D. A. Levine, U.S. Patent 20,130,078,319 (2013).
  2. [45]C. R. Behrens, B. Liu, in Mabs (Landes Bioscience, 2013), vol. 6, pp. 46–53.

Cited by

Sorted by citations

Authors
Williams, R. M., Lee, C., Galassi, T. V., Harvey, J. D., Leicher, R., Sirenko, M., Dorso, M. A., Shah, J., Olvera, N., Dao, F., Levine, D. A., & Heller, D. A.
Affiliations
  • Memorial Sloan Kettering Cancer Center (US)
  • Tri-Institutional PhD Program in Chemical Biology (US)
  • NYU Langone Health (US)
Corresponding author
Heller, Daniel A.
Venue
Science Advances
Published
2018-04-06
Volume
4
Issue
4
Pages
eaaq1090-eaaq1090
ISSN
2375-2548 (ISSN-L)
OpenAlex
W2801617804
Cited by
183
References
58
Citations by year
2026: 22 · 2025: 19 · 2024: 26 · 2023: 23 · 2022: 27 · 2021: 19 · 2020: 22 · 2019: 20 · 2018: 5
FWCI
6.05
Type
journal article
Language
en
Open access
Locations
  • Science Advances (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (New Innovator Award (DP2-HD075698), Cancer Center Support Grant (P30 CA008748))
  • U.S. Department of Defense (W81XWH-11-2-0230 and W81XWH-15-1-0429)
  • American Heart Association (Postdoctoral Fellowship (17POST33650043))
  • Honorable Tina Brozman Foundation
  • Memorial Sloan-Kettering Cancer Center
  • Frank A. Howard Scholars Program
  • Alan and Sandra Gerry Metastasis Research Initiative
  • Louis V. Gerstner Jr Young Investigator’s Fund
  • Frank Lappin Horsfall Jr, Fellowship
  • Ovarian Cancer Research Fund (Ann Schreiber Mentored Investigator Award 370463)
  • Hunter R. Rawlings III Cornell Presidential Research Scholars program
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
Keywords
high-grade serous ovarian cancer, HE4, CA125, optical nanosensors, implantable sensors, carbon nanotubes, non-invasive cancer detection, early cancer detection, orthotopic tumor model, in vivo optical imaging, biomarker detection
MeSH terms
Animals, Disease Models, Animal, Female, Humans, Neoplasm Staging, Ovarian Neoplasms, Biomarkers, Tumor, Biosensing Techniques, Cystadenocarcinoma, Serous, Nanotechnology, Mice, Optical Devices, Neoplasm Grading

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review